)
Zai Lab (ZLAB) investor relations material
Zai Lab 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic vision and business model
Operates a dual-engine model: a profitable commercial business in China and a growing global innovation portfolio.
Acts as a gateway for Western biotechs entering China and Chinese innovation expanding globally.
Integrated U.S.-China R&D model enables rapid, capital-efficient execution and industry-leading development speed.
Maintains a strong balance sheet with $817 million in cash as of September 2025, supporting ongoing investment in R&D.
Strategic capital allocation aims for near-term margin expansion and long-term profitability.
Pipeline and R&D highlights
Global pipeline focuses on immunology and oncology, emphasizing advanced modalities like ADCs and T-cell engagers.
Lead asset Zoci (DLL3 ADC) in phase III for small cell lung cancer, with potential US approval as early as 2028.
ZL-1503 (IL-13/31 bispecific) in phase I/1b for atopic dermatitis, with rapid and durable itch suppression in preclinical models.
Additional oncology programs (LRRC15 ADC, MUC17 x CD3) to enter or are in clinical trials in 2024.
R&D strategy balances internal discovery with selective in-licensing of late preclinical or early clinical assets.
Clinical data and differentiation
Zoci shows 68.4% ORR in second-line small cell lung cancer and 80% ORR in brain metastases without prior radiation.
Safety profile: only 13% grade 3+ TRAEs, no discontinuations or deaths, supporting use in combination regimens.
Phase III trial for Zoci initiated in Q4 2023, targeting 480 patients in real-world settings.
IL-13/31 program aims for rapid itch relief and longer duration in atopic dermatitis, targeting a $15–30 billion market.
LRRC15 ADC designed for broad-spectrum activity, including sarcomas and epithelial tumors, with phase I starting in 2024.
Next Zai Lab earnings date
Next Zai Lab earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)